非酒精性脂肪肝
代谢综合征
医学
内科学
纤维化
胃肠病学
脂肪肝
优势比
肝活检
疾病
活检
肥胖
作者
Yiwen Shi,Fangping He,Jinjun Chen,Hong Deng,Junping Shi,Caiyan Zhao,Yuqiang Mi,Zhengsheng Zou,Yongjian Zhou,Fusheng Di,Rui-dan Zheng,Qin Du,Jia Shang,Rui‐Xu Yang,Branko Popović,Bihui Zhong,Jian‐Gao Fan
出处
期刊:Journal of clinical and translational hepatology
[Xia & He Publishing]
日期:2021-04-23
卷期号:000 (000): 000-000
被引量:8
标识
DOI:10.14218/jcth.2021.00058
摘要
Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic disorders. This study aimed to explore the role of metabolic disorders in screening advanced fibrosis in NAFLD patients.A total of 246 histologically-proven NAFLD patients were enrolled across 14 centers. We compared the severity of fibrosis in patients with different components of metabolic disorders. Based on standard noninvasive tests and metabolic disorders, we developed new algorithms to identify advanced fibrosis.Metabolic syndrome (MetS) was frequent in NAFLD patients (133/246, 54%). Patients with MetS had a higher proportion of significant fibrosis (p=0.014) and higher LSM values (9.2 kPa, vs. 7.4 kPa, p=0.002) than those without MetS. Patients with more metabolic disorders had higher fibrosis stages (p=0.017). Reduced high-density lipoprotein cholesterol (odds ratio [OR]: 2.241, 95% confidence interval [CI]: 1.004-5.002, p=0.049) and raised fasting glucose (OR: 4.500, 95% CI: 2.083-9.725, p<0.001) were significantly associated with advanced fibrosis. Using these two metabolic disorders as a screening tool, a sensitivity, specificity and accuracy of 92%, 81% and 83% was achieved, respectively. With the new algorithms combining metabolic disorders with noninvasive measurements, the number of patients requiring liver biopsy was reduced, especially in combination with the Fibrosis-4 score and metabolic disorders (36% to 17%, p<0.001). In addition, this stepwise algorithm could achieve a high accuracy (85%) and high negative predictive value (93%).Metabolic disorders should be taken into consideration in the diagnosis of advanced fibrosis. With further validation and investigation, new algorithms could be recommended in primary care units to spare patients from unnecessary referral and liver biopsies.
科研通智能强力驱动
Strongly Powered by AbleSci AI